Back to today’s briefing

Story perspectives

Study Links Ozempic to 33% Increased Kidney Cancer Risk

6/5/2025

28 4

Summary

Story summary

A recent study reveals a troubling connection: Ozempic and similar weight-loss medications may elevate the risk of kidney cancer by 33%. Although they reduce the likelihood of other obesity-related cancers, these findings spark serious concerns. Researchers urge for deeper exploration, highlighting that the observed link is not yet definitively causal.

1 of 1

Story summary

A recent study reveals a troubling connection: Ozempic and similar weight-loss medications may elevate the risk of kidney cancer by 33%. Although they reduce the likelihood of other obesity-related cancers, these findings spark serious concerns. Researchers urge for deeper exploration, highlighting that the observed link is not yet definitively causal.